Summary and recommendation
Enfusion, the investment management platform serving hedge funds and asset managers, offers no SCIM provisioning capabilities on any plan. Despite being an enterprise SaaS solution with custom quote-based pricing that serves ~1000 institutional clients, Enfusion lacks both native SCIM support and integrations with major identity providers like Okta or Microsoft Entra. The platform doesn't even appear in the Okta Integration Network catalog, indicating minimal investment in modern identity management standards.
This creates a significant operational gap for IT teams managing access to critical financial systems. Without automated provisioning, organizations must manually create, update, and deactivate user accounts in Enfusion - a time-consuming process that introduces compliance risks in heavily regulated financial environments. The manual overhead becomes particularly problematic during employee onboarding, role changes, and offboarding, where delays in access management can impact trading operations or create security vulnerabilities.
The strategic alternative
Enfusion has no native SCIM. That leaves a workflow gap in offboarding, access reviews, and license cleanup unless your team handles the app another way. Stitchflow builds and maintains the IT workflows your team still runs manually, across every app, including the ones without APIs.
Quick SCIM facts
| SCIM available? | No |
| SCIM tier required | N/A |
| SSO required first? | No |
| SSO available? | Yes |
| SSO protocol | SAML 2.0 |
| Documentation | Not available |
Supported identity providers
| IdP | SSO | SCIM | Notes |
|---|---|---|---|
| Okta | Via third-party | ❌ | No Enfusion integration found in Okta OIN catalog |
| Microsoft Entra ID | Via third-party | ❌ | No Microsoft Entra provisioning documentation found for Enfusion |
| Google Workspace | Via third-party | ❌ | No native support |
| OneLogin | Via third-party | ❌ | No native support |
The cost of not automating
Without SCIM (or an alternative like Stitchflow), your IT team manages Enfusion accounts manually. Here's what that costs:
The Enfusion pricing problem
Enfusion gates SCIM provisioning behind premium plans, forcing significant cost increases for basic user management.
Tier comparison
| Plan | Price | SSO | SCIM |
|---|---|---|---|
| Enterprise | Custom quote |
Pricing structure
| Plan | Pricing | SCIM | SSO |
|---|---|---|---|
| Enterprise | Custom quote | ❌ Not available | Unknown |
Market context
What this means in practice
Without SCIM support, IT teams managing Enfusion deployments face entirely manual user lifecycle management:
For financial services organizations managing hundreds of users across multiple investment platforms, this creates significant operational overhead and compliance risk.
Additional constraints
Summary of challenges
- Enfusion does not provide native SCIM at any price tier
- Organizations must rely on third-party tools or manual provisioning
- Our research shows teams manually provisioning this app spend significant hidden costs annually
What Enfusion actually offers for identity
No Public Identity Management Features
Enfusion provides no publicly documented identity management capabilities:
| Feature | Supported? |
|---|---|
| SAML SSO | ❌ Unknown |
| OIDC SSO | ❌ Unknown |
| SCIM provisioning | ❌ No |
| API-based provisioning | ❌ Unknown |
| Directory sync | ❌ Unknown |
The reality: As an enterprise-only SaaS platform serving ~1000 institutional clients (hedge funds, asset managers, family offices), Enfusion likely offers some form of SSO integration for their custom enterprise deployments. However, none of this is publicly documented.
What This Means for IT Teams
The lack of public identity documentation means IT teams must navigate a complex enterprise sales process just to understand basic SSO and provisioning options.
What IT admins are saying
Enfusion's enterprise-only approach and lack of public integration documentation creates challenges for IT teams managing access:
- Manual user provisioning required - no SCIM or automated user lifecycle management
- No public SSO documentation despite serving major financial institutions
- Custom pricing model makes it difficult to budget for identity management features
- Post-acquisition uncertainty following Clearwater Analytics' $1.5B purchase in April 2025
We're managing 200+ users across multiple Enfusion modules and everything has to be done manually. For a platform serving hedge funds and asset managers, the lack of modern provisioning is surprising.
The sales team keeps saying 'everything is possible' but we can't find any public documentation on SAML or user provisioning. It's all custom implementation discussions.
The recurring theme
Despite serving sophisticated financial clients with complex compliance requirements, Enfusion lacks the modern identity management features that IT teams expect from enterprise software. Manual user management becomes a significant operational burden at scale.
The decision
| Your Situation | Recommendation |
|---|---|
| Small investment team (<10 users) | Manual management acceptable for now |
| Mid-size fund with stable team | Manual management with periodic review |
| Large asset manager (50+ users) | Use Stitchflow: manual processes don't scale |
| Multi-entity fund complex | Use Stitchflow: automation essential for consistency |
| Regulatory compliance requirements | Use Stitchflow: automated audit trail required |
The bottom line
Enfusion has no native SCIM. That means one more workflow gap in offboarding, access reviews, and license cleanup unless your team handles it another way.
Close the Enfusion workflow gap
Enfusion is one gap in a broader workflow. Stitchflow builds and maintains the offboarding, access review, or license workflow across every app in your environment.
Technical specifications
SCIM Version
Not specifiedSupported Operations
Not specifiedSupported Attributes
Plan requirement
Not specifiedPrerequisites
Not specifiedKey limitations
- No SCIM provisioning documentation found
- No public SSO/SAML integration documentation
- Enterprise SaaS with custom pricing only
- Acquired by Clearwater Analytics in April 2025 for $1.5B
- Serves ~1000 clients including hedge funds, asset managers, family offices
Documentation not available.
Close the workflow gap in
Enfusion
Enfusion has no native SCIM. That leaves one more workflow gap in offboarding, access reviews, and license cleanup unless your team handles it another way.
Start with the free gap diagnostic


